Naoko Nishimura Selected Research

Naoko Nishimura Research Topics

Disease

7	Infections 05/2016 - 01/2004
6	Whooping Cough (Pertussis) 01/2022 - 01/2014
5	Chickenpox 01/2023 - 01/2005
4	Pneumonia (Pneumonitis) 09/2014 - 11/2011
3	Fever (Fevers) 10/2019 - 06/2002
3	Human Influenza (Influenza) 11/2015 - 11/2011
2	Neurologic Manifestations (Neurological Manifestations) 12/2018 - 02/2014
2	Communicable Diseases (Infectious Diseases) 01/2018 - 10/2012
2	Brain Diseases (Brain Disorder) 11/2016 - 11/2011
2	Gastroenteritis 01/2016 - 12/2014
2	Enteritis 01/2016 - 11/2012
2	Anaphylaxis (Anaphylactic Shock) 11/2015 - 01/2005
2	Asymptomatic Infections 10/2014 - 10/2008
2	Cerebral Infarction 02/2014 - 07/2012
1	Cough 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Ulcer 01/2021
1	Neoplasms (Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Infarction (Infarctions) 12/2018
1	Embolic Stroke 12/2018
1	Edema (Dropsy) 12/2018
1	Inflammation (Inflammations) 12/2018
1	Vaccine-Preventable Diseases 07/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2016
1	Stroke (Strokes) 02/2014
1	Ischemic Stroke 02/2014
1	Cerebral Hemorrhage 02/2014
1	Thrombotic Stroke 02/2014
1	Tetanus 01/2014
1	Diphtheria 01/2014
1	Vomiting 11/2012
1	Diarrhea 11/2012
1	Pulmonary Embolism 01/2012
1	Thrombosis (Thrombus) 01/2012
1	Measles 05/2011
1	Hypoxia (Hypoxemia) 05/2010
1	Meningitis 10/2009
1	Seizures (Absence Seizure) 08/2008
1	Hyperoxia 12/2007
1	Hypocapnia 12/2007
1	Exanthema (Rash) 05/2007
1	Hypersensitivity (Allergy) 01/2005
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 06/2003

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 10/2019 - 06/2002
6	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 06/2003
4	AntigensIBA 01/2022 - 08/2008
4	Immunoglobulin G (IgG)IBA 05/2020 - 10/2014
4	SMTP 7IBA 12/2018 - 01/2012
3	AntibodiesIBA 01/2023 - 11/2015
3	PlasminogenIBA 12/2018 - 01/2012
3	Phenol (Carbolic Acid)FDA Link 12/2018 - 01/2012
3	CytokinesIBA 01/2014 - 01/2011
3	Chickenpox Vaccine (Vaccine, Varicella)IBA 11/2012 - 01/2005
2	Immunoglobulin E (IgE)IBA 11/2015 - 01/2005
2	ChemokinesIBA 11/2011 - 01/2011
2	Oxygen (Dioxygen)IBA 05/2010 - 12/2007
1	Protons (Proton)IBA 01/2021
1	Pertussis ToxinIBA 05/2020
1	Epoxide HydrolasesIBA 12/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2018
1	Acellular VaccinesIBA 01/2018
1	TransferasesIBA 11/2016
1	ran-binding protein 2IBA 11/2016
1	Carnitine (L-Carnitine)FDA LinkGeneric 11/2016
1	Bordetella pertussis Vag8IBA 05/2016
1	EnzymesIBA 05/2016
1	Immunoglobulin M (IgM)IBA 05/2016
1	ImmunosorbentsIBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 05/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	phenoxyethanol (2-phenoxyethanol)IBA 11/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2015
1	Rotavirus VaccinesIBA 12/2014
1	23S Ribosomal RNAIBA 09/2014
1	MacrolidesIBA 01/2014
1	Pertussis VaccineIBA 01/2014
1	ToxoidsIBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	C-Reactive ProteinIBA 11/2012
1	Nucleic AcidsIBA 10/2012
1	Anti-Infective Agents (Microbicides)IBA 10/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2012
1	Fibrinolysin FDA Link 01/2012
1	HMGB1 Protein (HMG1)IBA 11/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2011
1	Cytochromes c (Cytochrome c)IBA 11/2011
1	Rubella VaccineIBA 05/2011
1	Interleukin-5 (Interleukin 5)IBA 01/2011
1	Transaminases (Aminotransferases)IBA 08/2008
1	Viral AntigensIBA 08/2008
1	GelatinIBA 01/2005
1	Viral DNAIBA 01/2004

Therapy/Procedure

2	Radiotherapy 01/2021 - 01/2019
1	Therapeutics 02/2014
1	Intravenous Infusions 02/2014